GH secretagogues and uses thereof
US7316997B2 · kind B2 · utility
15Cited by
4References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 20, 2004 |
| Grant date | Jan 8, 2008 |
| Priority date | — |
| Expiry date | Oct 20, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/60
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to use of a GH secretagogue (e.g. GRF or an analog thereof) for (1) altering a lipid parameter in a subject; (2) altering a body composition parameter in a subject, (3) treating a condition characterized by deficient or decreased bone formation in a subject (4) improving daytime vigilance and/or cognitive function in a subject, (5) improving a metabolic condition in a subject, (6) improving anabolism in a catabolic condition in a subject, and/or (7) improving and/or reconstituting immune function in a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.